Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 57INDUSTRY 19NIH 9OTHER_GOV 5NETWORK 5UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 1

Conditions

Small Cell Lung Carcinoma 1

Interventions

apatinib 3Drug Therapy 3icotinib 2camrelizumab 2Radiotherapy 2Etoposide 2Erlotinib Hydrochloride 2Cisplatin 2tislelizumab 1pembrolizumab 1aumolertinib 1anlotinib 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Povidone-Iodine 1Pleurodesis 1Pemetrexed 1Nutrition Assessment 1Methylene Blue 1Lidocaine 1Irinotecan 1Indocyanine Green 1Immunotherapy 1Gemcitabine 1Gefitinib 1Chemoradiotherapy 1Celecoxib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Irinotecan × Thoracic × Clear all
NCT02323737 2014-12-30

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

ChineseAMS

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡